TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
FOCL

EDAP TMS S.A.

Healthcare · Medical Distribution

4.50$ -3.8% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns EDAP TMS S.A. (FOCL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.8% of the shares are freely tradable; institutional investors hold 39.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 39.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 76.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 47Mio.

Largest Shareholders

Institutions

Institutions FOCL
Name Stake (%) Shares Change (%) Date
Soleus Capital Management, L.P. 15.91 7,309,254 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 7.28 3,345,280 -0.2 03/31/2026
Rock Springs Capital Management LP 3.02 1,386,000 +0.6 06/30/2026
FLAX POND CAPITAL, LLC 1.70 783,446 -1.7 03/31/2026
Bruce & Co Inc 0.95 438,652 +0.0 03/31/2026
UBS Group AG 0.37 169,630 -19.8 03/31/2026
Parkman Healthcare Partners LLC 0.34 154,832 +0.0 06/30/2026
Essex Investment Management Company, LLC 0.32 146,005 +0.0 06/30/2026
OHE Financial Inc 0.29 134,960 +0.0 06/30/2026

Funds

Funds FOCL
Name Stake (%) Shares Change (%) Date
Bruce 0.90 414,794 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings FOCL
Person Role Shares Value As of Type
Willsey Lance Director 1,291,780 5,813,010 $ Aug 14, 2026 direct
Rhodes Ryan Chief Executive Officer 626,649 2,819,921 $ Aug 14, 2026 direct
Mobeck Kenneth S. Chief Financial Officer 181,610 817,245 $ Aug 14, 2026 direct
Annen Steven SVP, Marketing & Product Mgmt. 136,490 614,205 $ Aug 14, 2026 direct
Shah Sanket General Counsel & Corp Sec 72,500 326,250 $ Aug 14, 2026 direct
Levine Joshua Director 45,000 202,500 $ Aug 14, 2026 direct
Schulz Fran Director 15,100 67,950 $ Aug 14, 2026 direct
Horn David R. Director 10,000 45,000 $ Aug 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 14, 2026 Horn David R. Director Buy 10,000 4.75 47,500
Aug 14, 2026 Schulz Fran Director Buy 10,000 4.75 47,500
Aug 14, 2026 Levine Joshua Director Buy 10,000 4.75 47,500
Aug 14, 2026 Mobeck Kenneth S. Chief Financial Officer Buy 5,000 4.75 23,750
Aug 14, 2026 Willsey Lance Director Buy 50,000 4.75 237,500
Aug 14, 2026 Rhodes Ryan Chief Executive Officer Buy 21,000 4.75 99,750
Aug 14, 2026 Shah Sanket General Counsel & Corp Sec Buy 5,000 4.75 23,750
Aug 14, 2026 Annen Steven SVP, Marketing & Product Mgmt. Buy 5,000 4.75 23,750

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?